Sustainable Practices in Anti-VEGF Therapy: A 15-Year Bibliometric Analysis of Ranibizumab for Age-Related Macular Degeneration.

Xiaodong L, Xia C, Xuewei Q, Dandan W, Yi Y, Zhilin L

Open source

DOI
10.1155/joph/8891531
Published
2025
Container
Journal of ophthalmology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1155/joph/8891531,
  title = {Sustainable Practices in Anti-VEGF Therapy: A 15-Year Bibliometric Analysis of Ranibizumab for Age-Related Macular Degeneration.},
  author = {Xiaodong L and Xia C and Xuewei Q and Dandan W and Yi Y and Zhilin L},
  year = {2025},
  journal = {Journal of ophthalmology},
  doi = {10.1155/joph/8891531},
  url = {https://doi.org/10.1155/joph/8891531}
}

RIS

TY  - JOUR
TI  - Sustainable Practices in Anti-VEGF Therapy: A 15-Year Bibliometric Analysis of Ranibizumab for Age-Related Macular Degeneration.
AU  - Xiaodong L
AU  - Xia C
AU  - Xuewei Q
AU  - Dandan W
AU  - Yi Y
AU  - Zhilin L
PY  - 2025
JO  - Journal of ophthalmology
DO  - 10.1155/joph/8891531
UR  - https://doi.org/10.1155/joph/8891531
ER  - 

APA

L, X., C, X., Q, X., W, D., Y, Y., & L, Z. (2025). Sustainable Practices in Anti-VEGF Therapy: A 15-Year Bibliometric Analysis of Ranibizumab for Age-Related Macular Degeneration.. Journal of ophthalmology. https://doi.org/10.1155/joph/8891531

Source records